Top Markets
Coin of the day
Poolbeg Pharma PLC Poolbeg Pharma PLC

Poolbeg Pharma PLC

POLB
Classifica tra le azioni #38628
Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the... Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an intramuscular vaccine aimed at preventing Melioidosis. Beyond specific therapeutic candidates, Poolbeg also holds licensed access to advanced micro- and nanoencapsulation technology for an oral vaccine delivery system designed to stimulate gut immunity. The company further advances its research through an artificial intelligence-powered drug program. Additionally, Poolbeg is developing a biomarker platform to identify individuals at high risk of severe disease, alongside a model-derived vaccine discovery platform to pinpoint novel vaccine candidates. Incorporated in 2021, Poolbeg Pharma plc is headquartered in London.
Prezzo delle azioni
$0.11565963
Capitalizzazione di mercato
$882.99K
Variazione (1 giorno)
-2.30%
Variazione (1 anno)
189.81%
Paese
GB
Scambia Poolbeg Pharma PLC (POLB)

Categoria

Storico del prezzo dell'azione per Poolbeg Pharma PLC (POLB)
Prezzo di chiusura più alto: $0.12 il 2026-08-01

Prezzo di chiusura più basso: $0.15 il 2021-07-01
Storico del prezzo dell'azione di Poolbeg Pharma PLC dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 28.20%
2025 -42.87%
2024 -20.84%
2023 32.33%
2022 -27.62%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$507.94 30.14%
US
$846.71 29.78%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE